Methyl 2-chloro-1,3-benzoxazole-4-carboxylate(CAS: 1007112-35-7)

Methyl 2-chloro-1,3-benzoxazole-4-carboxylate (CAS: 1007112-35-7) is subject to the Reach regulation in the European Union, which requires manufacturers and importers to register substances with the European Chemicals Agency. It falls under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), with specific hazards such as skin and eye irritation. In the United States, the EPA may regulate it under the Toxic Substances Control Act (TSCA).

There are several alternatives to Methyl 2-chloro-1,3-benzoxazole-4-carboxylate in synthesis, such as methyl 2-bromo-1,3-benzoxazole-4-carboxylate or methyl 2-iodo-1,3-benzoxazole-4-carboxylate, which can serve as viable substitutes in certain reactions. These alternates can be used depending on the specific synthetic route and reactivity requirements.

The market for Methyl 2-chloro-1,3-benzoxazole-4-carboxylate (CAS: 1007112-35-7) is growing as it finds applications in pharmaceuticals and agrochemicals. Research trends indicate increasing interest in its use as a precursor for the synthesis of bioactive compounds and as an intermediate in drug development. Recent studies are exploring its potential in anti-inflammatory and antiviral drug candidates.

Waste containing Methyl 2-chloro-1,3-benzoxazole-4-carboxylate (CAS: 1007112-35-7) should be collected in appropriate containers and stored separately. It should be disposed of by incineration or professional waste disposal services to minimize environmental impact. Proper protective equipment and safety measures must be taken during handling to prevent exposure and accidental release into the environment.